Home
/
News
/
YHLO News
/
Global registration overview of YHLO diagnostic kits for Novel Coronavirus COVID-19 Antigen/Antibody

Global registration overview of YHLO diagnostic kits for Novel Coronavirus COVID-19 Antigen/Antibody

2022-06-21

Summary:

 

Previous: YHLO showcased at 13th International Congress on Autoimmunity
Next: Meet YHLO at 13th International Autoimmunity Congress in Greece
Home
About YHLO
Products
Services
News
Contact Us
Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +
关于亚辉龙
Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +
关于亚辉龙
Services

Services

YHLO aims to offer professional service with care and make service beyond expectations.

More +
关于亚辉龙
YHLO News Marketing Activities Publications Articles

News

Show you recent news, events and marketing activities about YHLO.

More +
关于亚辉龙
Contact Us

Contact Us

Tel: +86 755 26601910
Email: marketing@szyhlo.com
Website: www.szyhlo.com

More +
关于亚辉龙
Language
Search
languageLanguage language
亚辉龙

About YHLO

Products

Services

News

Join Us

关注我们

Wechat

Tel：
+86 755 26601910
E-mail：
marketing@szyhlo.com
Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Follow YHLO

wechatwechat wechat wechat wechat

© 2020  Shenzhen YHLO Biotech Co., Ltd.  All rights reserved.  粤ICP备17105123号